Iress (ASX: IRE) shares fall 11% as 47% cash EBITDA growth collides with weaker FY26 revenue guidance

Iress Limited (ASX: IRE) has delivered a 47.1% increase in first-half Cash EBITDA from its continuing businesses, yet its shares fell about 11% on August 17 after management cut FY26 revenue guidance and signalled that lower non-recurring revenue will persist through the second half. Continuing-business revenue increased only 2.5% in constant currency to A$250 million, while Cash EBITDA climbed to A$61.1 million and the Cash EBITDA margin expanded by more than 740 basis points to 24.5%. Iress also increased its fully franked interim dividend 27.3% to 14 cents per share and reduced net debt to A$70.2 million. The tension is unusually clear: the financial software company is becoming substantially more profitable without much additional revenue, but investors now need proof that cost-led margin expansion can transition into durable organic growth.

Iress shares were trading around A$7.04 shortly before the August 17 close, down approximately 11% from the previous A$7.91 close after touching A$7.01. Trading volume had reached about 3.2 million shares, almost four times the recent average shown by Google Finance. The decline leaves Iress roughly 32% below its A$10.38 52-week high, although the stock remains about 25% above the A$5.64 annual low.

The market reaction looks particularly severe beside the headline profit numbers. Statutory net profit increased approximately 85% to A$32 million, underlying profit after tax rose 18.4% to A$38.8 million on the reported headline basis, and underlying earnings per share increased to 20.8 cents. The cleaner continuing-business comparison is stronger still, with underlying profit after tax and underlying EPS both increasing 24.5%.

The problem is the revenue outlook. Iress reduced constant-currency FY26 revenue guidance from A$520 million to A$528 million to A$509 million to A$515 million, while simultaneously increasing Cash EBITDA guidance from A$116 million to A$123 million to A$121 million to A$126 million. The company now expects only 1% to 2% revenue growth but 21% to 26% Cash EBITDA growth, placing much more weight on structural efficiency rather than top-line expansion.

Why did Iress shares fall 11% when first-half Cash EBITDA increased more than 47%?

The simplest explanation is that the result improved the profit outlook while weakening the revenue story. At the midpoint, previous constant-currency revenue guidance of A$524 million has fallen to A$512 million, a reduction of A$12 million or approximately 2.3%. By contrast, Cash EBITDA midpoint guidance increased from A$119.5 million to A$123.5 million, an improvement of about A$4 million or 3.3%.

For a software company, that distinction matters. Margin expansion can create substantial shareholder value, particularly after a period of restructuring and portfolio simplification, but investors typically also want evidence that recurring software revenue can grow consistently once the easiest cost reductions have been captured.

Iress attributed the revenue revision primarily to A$7 million to A$8 million less non-recurring revenue than previously expected. Large client projects completed during the prior period also created a difficult comparison, with continuing-business non-recurring revenue declining 11.6% in constant currency during the first half. Recurring revenue was considerably more resilient, increasing 3.4% to A$237.8 million.

Recurring revenue now represents approximately 95% of the A$250 million continuing-business revenue base. That provides considerable earnings visibility, but it also makes the growth rate of those subscriptions increasingly important. A business with very high recurring revenue but only low-single-digit organic growth will be valued differently from one capable of combining recurrence with sustained mid-to-high-single-digit expansion.

The August 17 sell-off therefore appears less like rejection of the restructuring and more like a reset of expectations around how quickly Iress can move from improving margins to growing the revenue base.

How much of Iress’s earnings improvement came from cost reduction rather than revenue growth?

The first-half numbers provide an unusually clean answer. Continuing-business revenue increased by only A$0.6 million on a reported basis, from A$249.4 million to A$250 million. Operating costs, meanwhile, fell A$7.8 million to A$181.4 million. Adjusted EBITDA consequently rose A$8.4 million to A$68.6 million.

On a constant-currency basis, revenue increased 2.5% while operating expenses fell 1.9%. Cash EBITDA climbed 47.1%, helped further by a substantial reduction in capital expenditure following completion of a major execution-management-system project during 2025. Continuing-business capex fell from A$17.7 million to just A$7.5 million.

The earnings bridge makes the economics even clearer. Iress began with A$42.5 million of first-half 2025 continuing-business Cash EBITDA. Revenue contributed approximately A$6.4 million of improvement on a constant-currency basis, while staff costs added another A$0.8 million. Higher cost of sales reduced earnings by A$2.2 million, lower non-wage operating expenses added A$4.9 million and lower capital expenditure contributed approximately A$10.1 million. That produced A$62.5 million of constant-currency Cash EBITDA before a A$1.4 million currency impact reduced the reported result to A$61.1 million.

That means lower capital expenditure alone contributed more to the Cash EBITDA improvement than incremental revenue. This is not inherently negative because Iress defines Cash EBITDA after capital expenditure precisely to capture the cash intensity of software development. It does mean investors should avoid treating the 47.1% growth rate as though it resulted primarily from rapid customer or revenue expansion.

The quality test shifts into the second half. Iress has already told investors that capex will increase as its product-evolution program moves further into execution. FY26 profitability therefore needs to remain strong even as some of the unusually favourable first-half capex comparison begins to reverse.

Can another A$6 million to A$9 million of savings make Iress’s higher margins sustainable?

Iress says its Business Efficiency Program had delivered A$31.5 million of annualised efficiencies by June 30, ahead of plan. It expects another A$6 million to A$9 million of annualised savings during the second half, with the full benefit flowing through FY27.

At the midpoint, another A$7.5 million would take identified annualised efficiencies to approximately A$39 million. Relative to first-half continuing-business operating costs of A$181.4 million, that is a substantial structural reset, although annualised savings should not be directly deducted from a six-month expense base.

The first-half margin outcome suggests the program is already financially meaningful. Continuing-business adjusted EBITDA margin increased from 24.2% to 27.4%, while Cash EBITDA margin rose from 17% to 24.5%. Iress continues to target a 25% Cash EBITDA margin exit run rate for FY26.

The important question is what happens after the efficiency program matures. Management cannot repeatedly remove A$30 million to A$40 million from the cost structure without eventually reaching practical limits. The next phase needs operating leverage from revenue growth, product improvements and customer retention rather than another large restructuring round.

There is already some evidence that the remaining businesses can generate attractive margins individually. APAC Wealth produced A$24.5 million of Cash EBITDA on A$68.2 million of first-half revenue, implying a 36.1% Cash EBITDA margin. Global Trading and Market Data generated A$28.1 million on A$125.3 million of revenue for a 22.4% margin, while United Kingdom Wealth and Sourcing generated A$8.5 million on A$53.5 million of revenue for a 15.9% margin.

Those figures show why portfolio simplification matters. Iress is increasingly a company built around a small number of identifiable software franchises rather than a collection of businesses with very different economics.

Which Iress businesses are actually producing organic revenue growth after the divestments?

APAC Wealth generated A$68.2 million of first-half revenue, up 4.8% in constant currency, making it the strongest major continuing segment by revenue growth. Global Trading and Market Data increased 2% to A$125.3 million. United Kingdom Wealth and Sourcing moved in the opposite direction, with revenue declining 0.9% in constant currency to A$53.5 million.

The earnings progression was much stronger than the revenue progression across all three businesses. Global Trading and Market Data Cash EBITDA increased 62.3% in constant currency to A$28.1 million. APAC Wealth increased 39.4% to A$24.5 million, while United Kingdom Wealth and Sourcing increased 39.9% to A$8.5 million.

Again, that pattern demonstrates the strength of the cost reset but also the next strategic hurdle. Every major business produced far faster Cash EBITDA growth than revenue growth. Eventually, the gap must narrow because margin expansion cannot continue indefinitely.

Iress is now concentrating investment behind these continuing franchises after selling businesses including Managed Funds Administration, Platform, United Kingdom Mortgages, Pulse, Superannuation and QuantHouse. The Superannuation and QuantHouse transactions still have transitional-service arrangements expected to conclude during the fourth quarter of 2026, meaning some remaining simplification benefits are still to come.

The strategic end-state is therefore becoming much clearer. Iress needs APAC Wealth, Global Trading and Market Data and United Kingdom Wealth and Sourcing to produce sufficient recurring growth to support a software valuation without relying on earnings from businesses that have already been sold.

Will Iress’s Thoughtworks partnership and AI investment restart the revenue growth engine?

This is where the investment case becomes more forward-looking. Iress has mobilised its partnership with Thoughtworks to accelerate platform modernisation and product delivery, while artificial intelligence is being incorporated across its engineering strategy and Xplan roadmap. Management says second-half priorities include AI-enabled adviser workflow and productivity tools, a refreshed Client Portal and faster delivery across Wealth and Global Trading and Market Data.

The significance is financial as well as technological. Iress deliberately created additional investment capacity through cost reductions, but some of that cash now needs to be reinvested. Management has already signalled that capital expenditure will increase during the second half as the product-evolution program accelerates.

That creates a more demanding test than simply lowering expenses. The new investment has to improve customer retention, increase platform adoption, support price realisation, win new enterprise customers or produce additional recurring revenue. Otherwise, Iress risks replacing one cost base with another without materially changing its growth profile.

Artificial intelligence deserves similar discipline. Embedding AI into Xplan or internal engineering processes can improve productivity, but investors need measurable commercial outcomes rather than merely an expanding list of AI-enabled features. Iress itself has framed its second-half priority as translating AI capabilities into measurable customer value, an appropriately higher hurdle than simply deploying the technology.

The A$509 million to A$515 million constant-currency FY26 revenue guidance therefore becomes a baseline. If product investment works, FY27 should eventually show acceleration beyond the 1% to 2% growth now expected for FY26.

How much financial flexibility does Iress have after cutting net debt to A$70 million?

The balance sheet is considerably stronger than it was during the company’s earlier restructuring phase. Net debt was A$70.2 million at June 30, down from A$92.6 million a year earlier and A$291.7 million at the first half of 2024. Leverage has fallen from 2.3 times at 1H24 to 0.5 times.

That change materially increases Iress’s strategic flexibility. A company carrying less leverage can reinvest more confidently in product development while retaining the option to return capital or consider future strategic opportunities.

The dividend is one visible consequence. Iress declared a fully franked 14-cent interim dividend, up 27.3% from 11 cents, representing a payout ratio of approximately 67% of underlying earnings per share. Underlying EPS increased 18.4% on the headline comparison to 20.8 cents.

At an intraday share price around A$7.04, the 14-cent interim payment alone represents approximately 2% of the share price before considering the final dividend. More importantly, Iress now describes its approach as building sustainable dividends alongside the business rather than simply extracting capital during a restructuring.

The stronger balance sheet also changes how investors should judge future spending. Iress no longer needs cost reduction primarily to relieve financial pressure. Increasingly, those savings are meant to fund product evolution and create operating leverage. That raises the expected return on every dollar reinvested.

What are the key takeaways from Iress’s first-half FY26 results and revised guidance?

• Iress continuing-business revenue increased 2.5% in constant currency to A$250 million, with recurring revenue rising 3.4% to A$237.8 million.
• Continuing-business Cash EBITDA increased 47.1% to A$61.1 million and the Cash EBITDA margin expanded from 17% to 24.5%.
• Statutory NPAT increased approximately 85% to A$32 million, while continuing-business underlying profit after tax rose 24.5% to A$38.8 million.
• Iress reduced constant-currency FY26 revenue guidance to A$509 million to A$515 million from A$520 million to A$528 million.
• Cash EBITDA guidance was increased to A$121 million to A$126 million from A$116 million to A$123 million despite the lower revenue outlook.
• The Business Efficiency Program has delivered A$31.5 million of annualised savings, with another A$6 million to A$9 million targeted during the second half.
• Net debt declined to A$70.2 million and leverage fell to 0.5 times, providing considerably more financial flexibility than two years ago.
• Iress increased its fully franked interim dividend 27.3% to 14 cents per share.
• Second-half capital expenditure is expected to increase as Iress accelerates product investment, including work with Thoughtworks and AI-enabled Xplan capabilities.
• Iress shares were around A$7.04 late on August 17, down approximately 11%, as the market weighed stronger profitability against slower expected revenue growth.

What will prove whether Iress has moved from restructuring success to sustainable software growth?

Iress has achieved something financially significant. The company has simplified its portfolio, cut leverage from 2.3 times to 0.5 times, generated A$31.5 million of annualised efficiency savings and pushed continuing-business Cash EBITDA margins from 17% to 24.5% in one year. Those are tangible changes in the economics of the company rather than cosmetic adjustments to reporting.

The August 17 share-price decline highlights the next problem. Revenue growth has not yet caught up with profitability. Continuing-business revenue increased only 2.5% in constant currency, and management has reduced FY26 revenue guidance while increasing Cash EBITDA expectations. Cost discipline can continue lifting profits for a while, particularly with another A$6 million to A$9 million of annualised efficiencies planned, but it cannot substitute indefinitely for expanding recurring software revenue.

The strongest FY27 scenario would see Iress preserve a Cash EBITDA margin around or above its targeted 25% exit run rate while product investment produces faster recurring revenue growth. In that outcome, the efficiency program becomes the foundation for profitable expansion rather than the principal source of earnings growth.

The weaker scenario would be one in which revenue remains stuck around low-single-digit growth as capital expenditure rises and the easiest cost reductions run out. Margins could remain respectable, but the market would have less reason to assign Iress the valuation usually associated with faster-growing software platforms.

That makes the next measurable proof point remarkably simple. Iress has already demonstrated that it can make the business smaller, leaner and more profitable. Now it has to prove that the simplified business can grow.